Denosumab treatment for fibrous dysplasia.

Boyce, Alison M; Chong, William H; Yao, Jack; Gafni, Rachel I; Kelly, Marilyn H; Chamberlain, Christine E; Bassim, Carol; Cherman, Natasha; Ellsworth, Michelle; Kasa-Vubu, Josephine Z; Farley, Frances A; Molinolo, Alfredo A; Bhattacharyya, Nisan; Collins, Michael T

Boyce, Alison M; Chong, William H; Yao, Jack; Gafni, Rachel I; Kelly, Marilyn H; Chamberlain, Christine E; Bassim, Carol; Cherman, Natasha; Ellsworth, Michelle; Kasa-Vubu, Josephine Z; Farley, Frances A; Molinolo, Alfredo A; Bhattacharyya, Nisan; Collins, Michael T.

Affiliation

Boyce AM; Skeletal Clinical Studies Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.

J Bone Miner Res ; 27(7): 1462-70, 2012 Jul.

Article in En | MEDLINE | ID: mdl-22431375

Subject(s)

Antibodies, Monoclonal, Humanized/pharmacology; Fibrous Dysplasia of Bone/drug therapy; Mutation; Antibodies, Monoclonal/chemistry; Biopsy; Bone Neoplasms/secondary; Bone and Bones/pathology; Cell Membrane/metabolism; Cell Proliferation; Child; Denosumab; Humans; Immunohistochemistry/methods; Male; Neoplasm Metastasis; Osteoporosis; RANK Ligand/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Fibrous Dysplasia of Bone / Mutation Limits: Child / Humans / Male Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google